Member Exclusive News

The week in industry: GBP £45 million awarded to tackle life threatening diseases

This week: Ned Sharpless to become acting chief of the FDA, the SMC does not approve of KYMIRAH® for patients with lymphoma on the NHS and collaboration announced to advance treatments for dermatology conditions.

Mar 14, 2019
0
0

Please sign in or register for FREE

No comments yet.